Disease Course in Patients With Pentosan Polysulfate Sodium–Associated Maculopathy After Drug Cessation

Pearce, 2018, Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium., Ophthalmology, 125, 1793, 10.1016/j.ophtha.2018.04.026

Hanif, 2019, Strength of association between pentosan polysulfate and a novel maculopathy., Ophthalmology, 126, 1464, 10.1016/j.ophtha.2019.04.024

Hanif, 2019, Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study., JAMA Ophthalmol, 137, 1275, 10.1001/jamaophthalmol.2019.3392

Jain, Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort., Br J Ophthalmol

Huckfeldt, 2019, Progressive maculopathy after discontinuation of pentosan polysulfate sodium., Ophthalmic Surg Lasers Imaging Retina, 50, 656, 10.3928/23258160-20191009-10

Thévenaz, 1998, A pyramid approach to subpixel registration based on intensity., IEEE Trans Image Process, 7, 27, 10.1109/83.650848

Feuer, 2013, Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26., JAMA Ophthalmol, 131, 110, 10.1001/jamaophthalmol.2013.572

Invernizzi, 2018, Normative data for retinal-layer thickness maps generated by spectral-domain OCT in a white population., Ophthalmol Retina, 2, 808, 10.1016/j.oret.2017.12.012

Mititelu, 2013, Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging., JAMA Ophthalmol, 131, 1187, 10.1001/jamaophthalmol.2013.4244

Pham, 2019, Sequential changes in hydroxychloroquine retinopathy up to 20 years after stopping the drug: implications for mild versus severe toxicity., Retina, 39, 492, 10.1097/IAE.0000000000002408